Item 8.01. Other Events.
On March 4, 2025, Enveric Biosciences, Inc. (the "Company") received notice from the Nasdaq Office of General Counsel that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2), the bid price rule.
Attachments
Disclaimer
Enveric Biosciences Inc. published this content on March 06, 2025, and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on March 06, 2025 at 14:31:05.815.
